Advertisement
Screener

Boise Cascade Company (BCC) Spending and interest coverage

Boise Cascade Company (BCC) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 0.19%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months0.19%Share-based compensation / revenue. Period ending 2026-06-30.

$11.95M ÷ $6.46B × 100 ≈ 0.19%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue6.46B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation11.95M USDShare-based Payment Arrangement, Noncash Expense
Operating income160.04M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$6.46B$11.95M$160.04M(m)(m)0.19%(m)(m)
2026-03-31(m)$6.37B$11.82M$156.59M(m)(m)0.19%(m)(m)
2025-12-31(m)$6.40B$12.12M$183.33M(m)(m)0.19%(m)(m)
2025-09-30(m)$6.51B$13.89M$260.10M(m)(m)0.21%(m)(m)
2025-06-30(m)$6.56B$14.57M$345.12M(m)(m)0.22%(m)(m)
2025-03-31(m)$6.62B$15.14M$411.57M(m)(m)0.23%(m)(m)
2024-12-31(m)$6.72B$15.49M$490.04M(m)(m)0.23%(m)(m)
2024-09-30(m)$6.80B$15.56M$518.50M(m)(m)0.23%(m)(m)
2024-06-30(m)$6.92B$15.81M$586.77M(m)(m)0.23%(m)(m)
2024-03-31(m)$6.94B$16.19M$629.77M$25.20M(m)0.23%24.99×Reported
2023-12-31(m)$6.84B$15.41M$624.39M$25.50M(m)0.23%24.49×Reported
2023-09-30(m)$6.82B$14.70M$658.99M$25.49M(m)0.22%25.85×Reported
2023-06-30(m)$7.14B$13.98M$772.72M$25.54M(m)0.20%30.25×Reported
2023-03-31(m)$7.61B$12.80M$879.82M$25.52M(m)0.17%34.48×Reported
2022-12-31(m)$8.39B$11.87M$1.16B$25.41M(m)0.14%45.56×Reported
2022-09-30(m)$8.54B$10.92M$1.23B$25.27M(m)0.13%48.65×Reported
2022-06-30(m)$8.27B$9.81M$1.06B$25.16M(m)0.12%42.12×Reported
2022-03-31(m)$8.43B$8.21M$1.17B$25.18M(m)0.10%46.54×Reported
2021-12-31(m)$7.93B$7.91M$971.80M$24.81M(m)0.10%39.18×Reported
2021-09-30(m)$7.62B$7.67M$843.56M$24.67M(m)0.10%34.20×Reported
2021-06-30(m)$7.33B$7.98M$872.75M$25.39M(m)0.11%34.37×Reported
2021-03-31(m)$6.13B$8.24M$514.74M$25.68M(m)0.13%20.05×Reported
2020-12-31(m)$5.47B$7.82M$335.03M$26.22M(m)0.14%12.78×Reported
2020-09-30(m)$5.10B$7.80M$260.66M$26.65M(m)0.15%9.78×Reported
2020-06-30(m)$4.78B$7.25M$146.99M$26.18M(m)0.15%5.61×Reported
2020-03-31(m)$4.77B$7.45M$140.35M$26.04M(m)0.16%5.39×Reported
2019-12-31(m)$4.64B$7.97M$136.46M$26.05M(m)0.17%5.24×Reported
2019-09-30(m)$4.61B$7.95M$27.41M$26.12M(m)0.17%1.05×Reported
2019-06-30(m)$4.68B$8.17M$12.96M$26.17M(m)0.17%0.50×Reported
2019-03-31(m)$4.85B$8.74M$41.89M$26.27M(m)0.18%1.59×Reported
2018-12-31(m)$5.00B$8.83M$72.04M$26.19M(m)0.18%2.75×Reported
2018-09-30(m)$5.02B$9.69M$177.75M$25.75M(m)0.19%6.90×Reported
2018-06-30(m)$4.91B$10.02M$203.39M$25.46M(m)0.20%7.99×Reported
2018-03-31(m)(m)$10.01M$171.83M$25.37M(m)(m)6.77×Reported
2017-12-31(m)$4.43B$9.73M$141.15M$25.37M(m)0.22%5.56×Reported
2017-09-30(m)$4.26B$9.13M$116.55M$26.48M(m)0.21%4.40×Reported
2017-06-30(m)$4.10B$8.75M$91.85M$27.32M(m)0.21%3.36×Reported
2017-03-31(m)$4.00B$8.49M$87.27M$27.25M(m)0.21%3.20×Reported
2016-12-31(m)$3.91B$8.18M$79.58M$26.69M(m)0.21%2.98×Reported
2016-09-30(m)$3.87B$7.47M$90.28M$25.09M(m)0.19%3.60×Reported
2016-06-30(m)$3.79B$6.79M$99.41M$23.69M(m)0.18%4.20×Reported
2016-03-31(m)$3.70B$6.31M$98.91M$22.85M(m)0.17%4.33×Reported
2015-12-31(m)$3.63B$5.83M$103.19M$22.53M(m)0.16%4.58×Reported
2015-09-30(m)$3.62B$6.06M$124.38M$22.30M(m)0.17%5.58×Reported
2015-06-30(m)$3.61B$6.50M$140.13M$22.09M(m)0.18%6.34×Reported
2015-03-31(m)$3.62B$6.28M$148.68M$22.02M(m)0.17%6.75×Reported
2014-12-31(m)$3.57B$5.92M$145.55M$22.05M(m)0.17%6.60×Reported
2014-09-30(m)$3.51B$5.19M$138.07M$22.13M(m)0.15%6.24×Reported
2014-06-30(m)$3.40B$4.11M$112.36M$21.79M(m)0.12%5.16×Reported
2014-03-31(m)$3.30B$3.47M$88.68M$21.05M(m)0.11%4.21×Reported
2013-12-31(m)$3.27B$2.87M$98.76M$20.43M(m)0.09%4.83×Reported
2013-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-12-31(m)$2.78B$0.00$63.13M$21.76M(m)0.00%2.90×Reported
2012-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-12-31(m)$2.25B$0.00$-27.05M$18.99M(m)0.00%-1.42×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
ASPEN AEROGELS INC (ASPN)United States$0.440B-4.17
Capstone Holding Corp. (CAPS)United States$0.004B-0.15
OLENOX INDUSTRIES INC. (OLOX)United States$0.001B-0.42
QXO, Inc. (QXO)United States$12.730B-463.75